Vivex Biomedical Raises $7.4M for Stem Cell, Implant Technologies

Vivex Biomedical, a biomedical startup focusing on implant technologies and stem cell therapies, raised $7.4 million to use its technology for spinal fusion and other applications, according to an Atlanta Business Chronicle report.

Advertisement
Heather Linder

The company is developing bone re-growth stimulation technologies and has an adaptive stem cell line called Marrow Isolated Adult Multi-Lineage Inducible cells. Vivex aims to introduce its stem cell and implant technologies to the market by early 2014.

More Articles on Devices:
Alphatec Holdings to Reduce Workforce, Operating Expenses for French Affiliate
Trinity Orthopedics Acquires Expanding Concepts’ Patent Portfolio
8 Key Notes on Spine & Orthopedic Medical Device Companies

Agentic AI in healthcare: The transformational impact & how to prepare

Recommended Whitepaper

Advertisement

Next Up in Spinal Tech

  • Zavation acquires ChoiceSpine

    Zavation Medical has acquired ChoiceSpine, and Derek Kuyper will be CEO of the combined company, according to a Feb. 26…

    By: Carly Behm

  • Carlsmed's 2025 revenue soars 86%

    Carlsmed saw significant gains in fourth-quarter and 2025 revenue, according to financial results posted Feb. 25. Five things to know:…

    By: Carly Behm
Advertisement

Comments are closed.